BioCentury | May 20, 2013
Strategy

Let a thousand ideas bloom

...a commercial return in those areas." For example, he pointed to Shire's January acquisition of Lotus Tissue Repair Inc....
...to prevent retinopathy of prematurity (ROP) $30.6M up front plus $169M in milestones Mar-13 (compl) Lotus Tissue Repair Inc....
BioCentury | Apr 1, 2013
Finance

Back for thirds

...up to $200 million in milestones; and the acquisition this year of rare disease company Lotus Tissue Repair Inc....
BioCentury | Mar 11, 2013
Company News

Lotus Tissue Repair, Shire deal

...Shire disclosed in an SEC filing financial details of its acquisition of Lotus Tissue Repair. Shire acquired Lotus...
...front, plus up to $275 million in milestones (see BioCentury, Jan. 14 & Feb. 25). Lotus Tissue Repair Inc....
BioCentury | Feb 25, 2013
Company News

Lotus Tissue Repair, Shire deal

...the acquisition of Lotus Tissue Repair for an undisclosed upfront payment, plus milestones (see BioCentury, Jan. 14). Lotus Tissue Repair Inc....
BioCentury | Jan 14, 2013
Finance

Highlights of weekly biotech stock moves

...to 2,033p last week and $5.05 to $98.55 on NASDAQ after announcing it will acquire Lotus Tissue Repair Inc....
BioCentury | Jan 14, 2013
Company News

Lotus Tissue Repair, Shire deal

...Shire will acquire Lotus Tissue Repair for an undisclosed upfront payment, plus milestones. Shire will gain Lotus Tissue's...
...gained ABH001 through its 2011 acquisition of Advanced BioHealing Inc. (see BioCentury, July 4, 2011). Lotus Tissue Repair Inc....
BioCentury | Jan 9, 2013
Company News

Shire to acquire Orphan company Lotus Tissue Repair

...Shire plc (LSE:SHP; NASDAQ:SHPG) will acquire Lotus Tissue Repair Inc. (Cambridge, Mass.) for an undisclosed upfront payment, plus milestones...
...on Tuesday. On NASDAQ, the stock was up $2.53 to $95.48. Third Rock Ventures launched Lotus Tissue Repair...
BioCentury | Jan 19, 2012
Cover Story

Spreadin' the news

...Blueprint Medicines Cancer Venture (series A) $40 Sage Therapeutics Inc. Neurology Venture (series A) $35 Lotus Tissue Repair Inc....
BioCentury | Sep 5, 2011
Strategy

Back to School 2011: Innovation & collaboration

...OTCQX:INRLY), Vienna, Austria Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Karolinska Institute , Stockholm, Sweden Lotus Tissue Repair Inc....
...P2X ligand-gated ion channel 3 (P2X3) ; personalized cancer therapy company Blueprint Medicines ; and Lotus Tissue Repair Inc....
BioCentury | Jul 4, 2011
Company News

Lotus Tissue Repair, University of Southern California deal

...royalties. Lotus will be responsible for development of the technology. Further terms were not disclosed. Lotus Tissue Repair Inc....
Items per page:
1 - 10 of 13
BioCentury | May 20, 2013
Strategy

Let a thousand ideas bloom

...a commercial return in those areas." For example, he pointed to Shire's January acquisition of Lotus Tissue Repair Inc....
...to prevent retinopathy of prematurity (ROP) $30.6M up front plus $169M in milestones Mar-13 (compl) Lotus Tissue Repair Inc....
BioCentury | Apr 1, 2013
Finance

Back for thirds

...up to $200 million in milestones; and the acquisition this year of rare disease company Lotus Tissue Repair Inc....
BioCentury | Mar 11, 2013
Company News

Lotus Tissue Repair, Shire deal

...Shire disclosed in an SEC filing financial details of its acquisition of Lotus Tissue Repair. Shire acquired Lotus...
...front, plus up to $275 million in milestones (see BioCentury, Jan. 14 & Feb. 25). Lotus Tissue Repair Inc....
BioCentury | Feb 25, 2013
Company News

Lotus Tissue Repair, Shire deal

...the acquisition of Lotus Tissue Repair for an undisclosed upfront payment, plus milestones (see BioCentury, Jan. 14). Lotus Tissue Repair Inc....
BioCentury | Jan 14, 2013
Finance

Highlights of weekly biotech stock moves

...to 2,033p last week and $5.05 to $98.55 on NASDAQ after announcing it will acquire Lotus Tissue Repair Inc....
BioCentury | Jan 14, 2013
Company News

Lotus Tissue Repair, Shire deal

...Shire will acquire Lotus Tissue Repair for an undisclosed upfront payment, plus milestones. Shire will gain Lotus Tissue's...
...gained ABH001 through its 2011 acquisition of Advanced BioHealing Inc. (see BioCentury, July 4, 2011). Lotus Tissue Repair Inc....
BioCentury | Jan 9, 2013
Company News

Shire to acquire Orphan company Lotus Tissue Repair

...Shire plc (LSE:SHP; NASDAQ:SHPG) will acquire Lotus Tissue Repair Inc. (Cambridge, Mass.) for an undisclosed upfront payment, plus milestones...
...on Tuesday. On NASDAQ, the stock was up $2.53 to $95.48. Third Rock Ventures launched Lotus Tissue Repair...
BioCentury | Jan 19, 2012
Cover Story

Spreadin' the news

...Blueprint Medicines Cancer Venture (series A) $40 Sage Therapeutics Inc. Neurology Venture (series A) $35 Lotus Tissue Repair Inc....
BioCentury | Sep 5, 2011
Strategy

Back to School 2011: Innovation & collaboration

...OTCQX:INRLY), Vienna, Austria Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Karolinska Institute , Stockholm, Sweden Lotus Tissue Repair Inc....
...P2X ligand-gated ion channel 3 (P2X3) ; personalized cancer therapy company Blueprint Medicines ; and Lotus Tissue Repair Inc....
BioCentury | Jul 4, 2011
Company News

Lotus Tissue Repair, University of Southern California deal

...royalties. Lotus will be responsible for development of the technology. Further terms were not disclosed. Lotus Tissue Repair Inc....
Items per page:
1 - 10 of 13